• OPEN AN ACCOUNT
Indian Indices
Sensex
76,816.54 756.77
( 0.99%)
Global Indices
Nasdaq
51,969.87 237.22
(0.46%)
Dow Jones
7,434.30 5.00
(0.07%)
Hang Seng
64,889.11 277.96
(0.43%)
Nikkei 225
10,738.51 99.34
(0.93%)
Forex
USD-INR
96.67 0.19
(0.20%)
EUR-INR
110.18 0.12
(0.10%)
GBP-INR
129.04 -0.01
(0.00%)
JPY-INR
0.59 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
27.4543251
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
9.72
30.04
EPS(TTM)
Face Value()
Div & Yield %
3.6
10
0
 

emerald finance ltd
Niyogin Fintech climbs after strong Q4 performance
Apr 10,2026
In Q4 FY26, IserveU Tech Net revenue stood at Rs 21.2 crore, up 56% YoY. The iServeU Tech order book now stands at Rs 610 crore, while iServeU recorded a full-year net revenue of Rs. 74.9 crores for FY26.

Tashwinder Singh, CEO and managing director, Niyogin Fintech said, “Our lending business recorded strong AUM growth during the quarter, driven by new partnerships and continued portfolio expansion. iServeU delivered solid year-on-year revenue growth supported by a stable order book, positioning us well to build further momentum in the coming quarters.”

The company’s current market capitalization is Rs 531.99 crore.

Niyogin Fintech caters to India’s underserved MSMEs and is a B2B company. It ties up with business correspondents, banks and neobanks/fintechs to offer banking as a service (BaaS) platforms, while it provides credit and other financial services through its financial professional network.